Versigent $VGNT Holdings Increased by VIRGINIA RETIREMENT SYSTEMS ET Al

Versigent logo with background
Image from MarketBeat Media, LLC.

Key Points

  • Virginia Retirement Systems increased its Versigent stake by 321.3% in the third quarter, acquiring 184,888 additional shares and bringing its holdings to 242,425 shares valued at approximately $10.9 million. Several other institutional investors also initiated positions.
  • Insider selling continued, with director Kevin Clark selling 47,761 shares for about $2.1 million; insiders have sold 220,000 shares worth approximately $10.1 million over the past 90 days. Analyst sentiment remains broadly positive, with a consensus “Moderate Buy” rating and a $54 target price.
  • Versigent reported quarterly EPS of $1.92, beating estimates of $1.58, while revenue of $2.44 billion exceeded expectations. The company pays a quarterly dividend of $0.13 per share, equivalent to a 1.3% annualized yield.
  • MarketBeat previews top five stocks to own in December.

VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in Versigent (NYSE:VGNT - Free Report) by 321.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 242,425 shares of the company's stock after acquiring an additional 184,888 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al owned about 0.34% of Versigent worth $10,895,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Wellington Management Group LLP purchased a new position in Versigent during the second quarter worth about $940,000. Raiffeisen Bank International AG acquired a new stake in Versigent in the second quarter valued at about $1,182,000. HBK Investments L P purchased a new stake in Versigent in the 2nd quarter valued at approximately $14,439,000. Steamboat Capital Partners LLC purchased a new stake in Versigent in the 2nd quarter valued at approximately $10,385,000. Finally, WINTON GROUP Ltd purchased a new stake in Versigent in the 2nd quarter valued at approximately $8,397,000.

Insider Activity at Versigent

In other news, Director Kevin Clark sold 47,761 shares of the business's stock in a transaction that occurred on Thursday, October 8th. The stock was sold at an average price of $44.36, for a total transaction of $2,118,677.96. Following the sale, the director owned 27,571 shares of the company's stock, valued at $1,223,049.56. The trade was a 63.40% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last 90 days, insiders sold 220,000 shares of company stock worth $10,065,848.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on VGNT shares. Evercore reiterated an "outperform" rating and set a $65.00 target price on shares of Versigent in a research report on Monday, August 10th. Zacks Research cut Versigent from a "hold" rating to a "strong sell" rating in a report on Thursday, October 15th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a $54.00 price target on shares of Versigent in a research note on Wednesday, August 5th. Fox Advisors lowered Versigent from an "overweight" rating to an "equal weight" rating in a report on Wednesday, August 5th. Finally, Wells Fargo & Company upped their price objective on Versigent from $48.00 to $56.00 and gave the stock an "overweight" rating in a report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, Versigent has a consensus rating of "Moderate Buy" and a consensus target price of $54.00.

Read Our Latest Research Report on VGNT

Versigent Stock Down 3.2%

Shares of NYSE VGNT opened at $40.95 on Friday. The company has a quick ratio of 1.09, a current ratio of 1.40 and a debt-to-equity ratio of 7.29. Versigent has a 52 week low of $26.34 and a 52 week high of $50.88. The firm has a 50-day moving average price of $45.48 and a 200 day moving average price of $42.74. The stock has a market capitalization of $2.90 billion and a price-to-earnings ratio of 21.33.

Versigent (NYSE:VGNT - Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.92 EPS for the quarter, topping analysts' consensus estimates of $1.58 by $0.34. The company had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.29 billion. Equities research analysts anticipate that Versigent will post 7.23 EPS for the current fiscal year.

Versigent Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Friday, September 4th were given a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date was Friday, September 4th.

Versigent Profile

(Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.

Featured Stories

Want to see what other hedge funds are holding VGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Versigent (NYSE:VGNT - Free Report).

Institutional Ownership by Quarter for Versigent (NYSE:VGNT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Versigent Right Now?

Before you consider Versigent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.

While Versigent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines